Lightnews — Scholar-powered news

Reposted by IPC Partners

British Infection Association @biainfection.bsky.social · 2m

🎙️ Introducing MIC – new BIA podcast! 🦠

Launching 16 Oct, join Dr Amy Belfield & Dr Michael Blank as they chat with authors from Journal of Infection & Clinical Infection Practice.

🎧 Teaser’s live! share.descript.com/view/O8t3o3S...

#MICpodcast #InfectiousDiseases #BIApodcast #InfectionScience

1

Reposted by IPC Partners

Journal of Hospital Infection @thejhi.bsky.social · 36m

An escape room game boosted healthcare workers' MDRO management knowledge, with retention high at three months post-training. Participants rated it 9.3/10, and the model could work for various specialties! https://www.journalofhospitalinfection.com/article/S0195-6701(25)00271-3/fulltext

1 2

Reposted by IPC Partners

WHO @who.int · 1h

A simple pair of glasses transformed Nguyen’s life; sharpening her vision, boosting her confidence, and bringing joy to everyday moments.

On #WorldSightDay, her story is a reminder that basic eye care isn’t a luxury, it is a fundamental right 👉 bit.ly/4odWmRP

Graphic showing Nguyen, a factory worker, sitting at a sewing machine and smiling. Text reads: “Nguyen, a factory worker with over two decades on the sewing line, found even routine tasks challenging as her eyesight began to deteriorate.”

Graphic with orange background and text: “Nguyen’s life changed with a simple pair of eyeglasses. Clear vision transforms both work and daily life. It’s not just about being able to see. It’s about dignity.” Includes a small circular photo of Nguyen smiling while wearing glasses.

13 54

Reposted by IPC Partners

British Infection Association @biainfection.bsky.social · 1h

🎙️ Introducing MIC – new BIA podcast! 🦠

Launching 16 Oct, join Dr Amy Belfield & Dr Michael Blank as they chat with authors from Journal of Infection & Clinical Infection Practice.
🎧 Teaser’s live! share.descript.com/v...

#MICpodcast #InfectiousDiseases #BIApodcast #InfectionScience

1

Reposted by IPC Partners

British Infection Association @biainfection.bsky.social · 2h

With just 1 week to go, register now & don’t miss out on BIA Autumn Trainees Meeting 2025! 📣

If you're a trainee in infection, this one is for you. Find out more & register now 👉 fitwise.eventsair.co...

#InfectionTrainees #InfectionEvent #Infection #VirtualEvent #BIATraineesDay2025

1

Reposted by IPC Partners

WHO @who.int · 3h

It's #WorldSightDay

Prolonged screen or reading times can lead to eye strain, dry eyes, and headaches.

DO take breaks!

Use the 20-20-20 rule to help your eyes:
🖥️ After using a screen for 20 minutes
📏 Look at an object 20 feet away
🕓 For 20 seconds

Infographic titled “Avoid eye strain & headaches – follow the 20-20-20 rule”. It explains:
After 20 minutes spent using a screen, look at an object 20 feet (6 metres) away for at least 20 seconds.

44 78

Reposted by IPC Partners

Tedros Adhanom Ghebreyesus @drtedros.who.int · 3h

I welcome President Trump's announcement about the ceasefire in #Gaza & hostage release. It is a big step towards lasting peace for both Israelis & Palestinians. I hope all parties will respect the agreement, so the suffering of all civilians finally ends & all hostages are brought home respectfully

1 7 14

Reposted by IPC Partners

WHO @who.int · 5h

Today is #WorldSightDay

Cataract is one of the leading causes of vision impairment and blindness, affecting 94 million people worldwide.

Don’t take your eyes for granted. Regular eye exams and timely treatment can prevent vision loss. Learn more 👉 bit.ly/3IUPrO7

Infographic titled “5 Things to Know About Cataract”. It lists:

- It’s the leading cause of blindness.
- It’s cloudiness in the lens of the eye.
- Cataract surgery is the only treatment.
- It affects adults and children.
- Regular eye exams and timely treatment can prevent vision loss.

34 100

Reposted by IPC Partners

Clinical Infectious Diseases @cidjournal.bsky.social · 14h

Precision Prevention of Tuberculosis in Biologic Therapy: Lessons Beyond Screening Strategies

✅ Just Accepted
#IDSky
🔗 https://bit.ly/42vkeYy

1 3

Reposted by IPC Partners

Clinical Infectious Diseases @cidjournal.bsky.social · 15h

AI in ID practice: diagnostics, stewardship, education & surveillance. CID wants papers exploring real-world benefits & risks. Proposals due Nov 2.

Learn more ⬇️

Joint Call for Papers: Leveraging AI Technologies for Discoveries and Solutions in Infectious Diseases

The IDSA journals are seeking papers focused on artificial intelligence (AI) and how it enhances and impacts infectious diseases. The journals are interested in

bit.ly

3 2

IPC Partners @ipcpartners.bsky.social · 18h

We had a great discussion with Alexandra Peters on Journal Club today about healthcare environmental hygiene. Here’s the recording youtu.be/EGcUwBdK3wM?...

Improving healthcare environmental hygiene helps to keep patients safe (IPC Journal Club)

YouTube video by IPC Partners

youtu.be

1 1

Reposted by IPC Partners

UK Health Security Agency @ukhsa.bsky.social · 18h

If you test positive for #HIV, treatment is highly effective, and most can expect to live a long, healthy life.

Early diagnosis can be lifesaving, so please get tested regularly if you’re sexually active.

Visit the NHS website to check your options: https://t.co/rvJOa6bo28 https://t.co/TxoVjMSA1n

Did you know? More than half the people in the UK living with HIV are now over 50. Thanks to testing and treatment, people can live long, healthy lives.

7 19

Reposted by IPC Partners

The Journal of Infectious Diseases @jidjournal.bsky.social · 19h

New JID supplement explores PEPFAR's infrastructure investments and their impact on global health security. Essential reading for global health policy experts and infection control professionals.

Available now ↪️ https://bit.ly/46mTcVG

1 2 2

Reposted by IPC Partners

European Centre for Disease Prevention and Control @ecdc.europa.eu · 20h

🧬 New #ECDC e-learning now available!
Essentials of SARS-CoV-2 sequencing and data analysis

A beginner-level course introducing next generation sequencing (NGS) with a focus on #SARSCoV2 - featuring Illumina, IonTorrent and Nanopore technologies.

🔗 bit.ly/4q2rrtk
#ECDCTraining #NGS #PublicHealth

1 4 6

Reposted by IPC Partners

European Centre for Disease Prevention and Control @ecdc.europa.eu · 20h

🚀 We’re hiring!

#ECDC is looking for new leaders to strengthen Europe’s defences against infectious diseases.

🧭 Head of Unit – Resource Management Services
🗣️ Head of Section – Science & Public Health Communication

📅 Apply by early November → bit.ly/ECDCjobs

#ECDC #EUJobs #EUCareers

1 10 8

Reposted by IPC Partners

European Centre for Disease Prevention and Control @ecdc.europa.eu · 20h

🧬 New #GenEpiBioTrain course!

Bacterial Strain Taxonomy for Genomic Surveillance
📅 22–23.10, 09:00–12:00 (CEST)

Learn how bacterial pathogens are classified & named in genomic surveillance – from #MLST & #cgMLST to SNP-based & k-mer clustering.

Info: bit.ly/48qT5df
#ECDCTraining #IDsky #EpiSky

2 5 7

Reposted by IPC Partners

European Food Safety Authority @efsa.europa.eu · 22h

📣 Just published | 4th joint monthly report on #WestNileVirus with @ecdc.europa.eu

➡️ Belgium reports its first WNV outbreaks in wild birds – a new EU country affected
➡️ 989 human cases & 63 deaths across 13 countries
➡️ 127 equid & 217 bird outbreaks across 9 countries

More 👉 link.europa.eu/fNP38x

High Magnification Microscopy of Malaria Infected Mosquito.

10 12

Reposted by IPC Partners

The Lancet Infectious Diseases @thelancetinfdis.bsky.social · 1d

New Review

Core outcome measurement set for clinical trials in dengue: an international Delphi consensus study (DEN-CORE)

www.thelancet.com/journals/lan...

Core outcome measurement set for clinical trials in dengue: an international Delphi consensus study (DEN-CORE)

Dengue, caused by any one of four distinct virus serotypes, is the most rapidly spreading mosquito-borne viral disease worldwide. It is a primary arboviral infection with increasing global incidence, ...

www.thelancet.com

3 1

Reposted by IPC Partners

The Lancet Infectious Diseases @thelancetinfdis.bsky.social · 1d

New Research

Long-term risk of tuberculosis among individuals with Xpert Ultra trace screening results in Uganda: a longitudinal follow-up study

www.thelancet.com/journals/lan...

Long-term risk of tuberculosis among individuals with Xpert Ultra trace screening results in Uganda: a longitudinal follow-up study

Individuals with trace-positive sputum during screening have a substantial 2-year risk of tuberculosis, even when extensive initial evaluations do not confirm disease. Treatment should be considered f...

www.thelancet.com

1 2 1

Reposted by IPC Partners

The Lancet Infectious Diseases @thelancetinfdis.bsky.social · 1d

New Review

The Emerging Resistance Index: tracking early resistance to new antibiotics

www.thelancet.com/journals/lan...

The Emerging Resistance Index: tracking early resistance to new antibiotics

The high clinical burden of antimicrobial resistance (AMR) and the dwindling antibiotic pipeline demand standardised tools to monitor resistance development to new antibiotics. The Emerging Resistance...

www.thelancet.com

2

Reposted by IPC Partners

The Lancet Infectious Diseases @thelancetinfdis.bsky.social · 1d

New Research

Characterising household transmission dynamics of clade Ib mpox in Burundi: a prospective cohort study

www.thelancet.com/journals/lan...

Characterising household transmission dynamics of clade Ib mpox in Burundi: a prospective cohort study

Intrahousehold transmission of clade 1b mpox in Burundi was limited, and unlikely to sustain a broader community spread. The involvement of children in transmission chains within the household undersc...

www.thelancet.com

1 1 1

Reposted by IPC Partners

The Lancet Infectious Diseases @thelancetinfdis.bsky.social · 1d

New Research

Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trial

www.thelancet.com/journals/lan...

Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised t...

Among patients with a hospital-acquired or health-care-associated Gram-negative bloodstream infection, cefiderocol resulted in non-inferior 14-day mortality compared with standard of care. Adverse eve...

www.thelancet.com

3 4

Reposted by IPC Partners

WHO @who.int · 1d

For over 50 years, Muthuramalingam has brought vision and hope to tens of thousands across rural India.

At 67, he is restoring sight, one child, one elderly villager, one pair of eyeglasses at a time. 👉 bit.ly/46Pfu2J #WorldSightDay

Graphic with the text: “Restoring sight, one pair of eyeglasses, one child, one elderly villager at a time.” Below, a quote reads: “Eye care is not just treating vision. It is giving people a whole new life.” A small circular photo shows a man examining a patient’s eyes with an ophthalmoscope. The background is green with a subtle paper texture and a small eyeglasses icon at the bottom.

17 82

Reposted by IPC Partners

British Infection Association @biainfection.bsky.social · 1d

FIS International 2025 Social Events 🥂

Come along this year for one or both of these exciting social events 👇
⭐ The Lowbury Reception
⭐ FIS 2025 Social Evening

👉 fitwise.eventsair.co...

#IPC #InfectionPrevention #infection #InfectiousDiseases #microbiology #IDSky

1 2 1

Reposted by IPC Partners

Healthcare Infection Society @hisinfection.bsky.social · 1d

📗The Journal of Hospital Infection is seeking two new Editors to join the team. This is an exciting opportunity to play a leading role in shaping the direction of a high-impact research journal in infection prevention and control

▶️Apply now: https://ow.ly/yzmE50X7LeE

1 2 1